Bisphosphonate associated osteonecrosis of the jaw (onj) in cancer patients: Conservative management techniques and consolidated guidelines

International Journal of Clinical Dentistry

Volumn 2, Issue 4, 2009, Pages 271-282

  Van den Wyngaert, Tim ^a   Huizing, Manon T ^a   Vermorken, Jan B ^a   Fossion, Eric ^b  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b ZNA Middelheim ^*  (Belgium)

Author keywords

Bisphosphonate; Cancer patients; Osteonecrosis

Indexed keywords

EID: 77954302802     PISSN: 19395833     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J. Oral. Maxillofac. Surg. 2003; 61: 1115-1117.
2. Devogelaer JP. Clinical use of bisphosphonates. Curr. Opin. Rheumatol. 1996; 8: 384-391.
3. Ross JR, Saunders Y, Edmonds PM et al. Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer. BMJ. 2003; 327: 469-474.
4. Advisory Task Force on Bisphosphonate-Related Osteonecrosis of the Jaws. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J. Oral. Maxillofac. Surg. 2007; 65: 369-376.
5. Bagan J, Blade J, Cozar JM et al. Recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw (ONJ) in cancer patients treated with bisphosphonates. Med. Oral. Patol. Oral. Cir. Bucal. 2007; 12: E336-40.
6. Khosla S, Burr D, Cauley J et al. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 2007; 22: 1479-1491.
7. Khan AA, Sandor GK, Dore E et al. Canadian consensus practice guidelines for bisphosphonate associated osteonecrosis of the jaw. J. Rheumatol. 2008; 35: 1391-1397.
8. Van den Wyngaert T, Huizing MT, Vermorken JB. Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy? Ann. Oncol. 2006; 17: 1197-1204.
9. Wang EP, Kaban LB, Strewler GJ et al. Incidence of Osteonecrosis of the Jaw in Patients With Multiple Myeloma and Breast or Prostate Cancer on Intravenous Bisphosphonate Therapy. J. Oral. Maxillofac. Surg. 2007; 65: 1328-1331.
10. Bamias A, Kastritis E, Bamia C et al. Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: incidence and risk factors. J. Clin. Oncol. 2005; 23: 8580-8587.
11. Hoff AO, Toth BB, Altundag K et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J. Bone Miner. Res. 2008; 23: 826-836.
12. Van den Wyngaert T, Huizing MT, Vermorken JB. Osteonecrosis of the jaw related to the use of bisphosphonates. Curr. Opin. Oncol. 2007; 19: 315-322.
13. Migliorati CA, Casiglia J, Epstein J et al. Managing the care of patients with bisphosphonate-associated osteonecrosis: an American Academy of Oral Medicine position paper. J. Am. Dent. Assoc. 2005; 136: 1658-1668.
14. Ruggiero S, Gralow J, Marx R et al. Practical Guidelines for the Prevention, Diagnosis, and Treatment of Osteonecrosis of the Jaw in Patients With Cancer. J. Oncol. Pract. 2006; 2: 7-14.
15. Woo SB, Hellstein JW, Kalmar JR. Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws. Ann. Intern. Med. 2006; 144: 753-761.
16. Saussez S, Javadian R, Hupin C et al. Bisphosphonate-related osteonecrosis of the jaw and its associated risk factors: a Belgian case series. Laryngoscope. 2009; 119: 323-329.
17. Nobuto T, Suwa F, Kono T et al. Microvascular response in the periosteum following mucoperiosteal flap surgery in dogs: angiogenesis and bone resorption and formation. J. Periodontal. 2005; 76: 1346-1353. (Pubitemid 41245780)
18. Dimopoulos MA, Kastritis E, Bamia C et al. Reduction of osteonecrosis of the jaw (ONJ) after implementation of preventive measures in patients with multiple myeloma treated with zoledronic acid. Ann. Oncol. 2009; 20: 117-120.
19. Ripamonti CI, Maniezzo M, Campa T et al. Decreased occurrence of osteonecrosis of the jaw after implementation of dental preventive measures in solid tumour patients with bone metastases treated with bisphosphonates. The experience of the National Cancer Institute of Milan. Ann. Oncol. 2009; 20: 137-145.
20. Montefusco V, Gay F, Spina F et al. Antibiotic prophylaxis before dental procedures may reduce the incidence of osteonecrosis of the jaw in patients with multiple myeloma treated with bisphosphonates. Leuk. Lymphoma. 2008; 49: 2156-2162.
21. Hansen T, Kunkel M, Springer E et al. Actinomycosis of the jaws-histopathological study of 45 patients shows significant involvement in bisphosphonate-associated osteonecrosis and infected osteoradionecrosis. Virchows. Arch. 2007; 451: 1009-1017.
22. Murray P, Rosenthal K, Kobayashi G, Pfaller M. Medical Microbiology. St. Louis, Missouri: Mosby; 1998.
23. LeCorn DW, Vertucci FJ, Rojas MF et al. In vitro activity of amoxicillin, clindamycin, doxycycline, metronidazole, and moxifloxacin against oral Actinomyces. J. Endod. 2007; 33: 557-560.
24. Papapoulos SE, Cremers SC. Prolonged bisphosphonate release after treatment in children. N. Engl. J. Med. 2007; 356: 1075-1076.
25. Van den Wyngaert T, Claeys T, Huizing MT et al. Initial experience with conservative treatment in cancer patients with osteonecrosis of the jaw (ONJ) and predictors of outcome. Ann. Oncol. 2009; 20: 331-336.
26. Badros A, Terpos E, Katodritou E et al. Natural history of osteonecrosis of the jaw in patients with multiple myeloma. J. Clin. Oncol. 2008; 26: 5904-5909.
27. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management. Oral. Surg. Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 2006; 102: 433-441.
28. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention, and treatment. J. Oral. Maxillofac. Surg. 2005; 63: 1567-1575.
29. Engroff SL, Kim DD. Treating bisphosphonate osteonecrosis of the jaws: is there a role for resection and vascularized reconstruction? J. Oral Maxillofac Surg 2007; 65: 2374-2385.